© 2025 MJH Life Sciences™ , Patient Care Online – Primary Care News and Clinical Resources. All rights reserved.
Latest Conference Articles
Study: “Worrisome” Changes in Cardiovascular Function Immediately after Vaping, Smoking Traditional Cigarettes
November 4th 2022
AHA 2022: Chronic users of either e-cigarettes or traditional cigarettes had acute changes in cardiovascular function and performed worse on exercise stress testing than never users in new study.
Wearable Device Uptake Low Among Adults with Cardiovascular Disease, Nationally Representative Study Finds
November 2nd 2022
AHA 2022: An estimated 18% of Americans with heart disease reported using wearables, compared with 29% of the total US population.
Perceived Discrimination Impairs Post-MI Recovery in Young Adults, Study Warns
November 2nd 2022
AHA 2022. A perception of discrimination was associated with worse mental health and disease-related health status 1 year post-MI among adults aged ≤55 years.
Tirzepatide Led to Clinically Meaningful Improvements in Body Composition in Adults with Obesity/Overweight
November 1st 2022
ObesityWeek 2022: Tirzepatide-induced weight reduction was associated with body composition improvements in adults with obesity/overweight, found analysis of SURMOUNT-1.
Physicians Should Get Patients to Move More to Help with Cardiometabolic Health, Says One Expert
October 26th 2022
Cardiometabolic Health Congress
To help patients improve their cardiometabolic health, encourage them to move more, according to one speaker from CMHC 2022.
High- vs Standard-dose Dexamethasone Could Pose Risks for Ventilated COVID-19 Patients
October 25th 2022
High-dose dexamethasone is often prescribed for critically ill COVID-19 patients although there is no evidence for its efficacy. A new study looked deeper.
Fluticasone Exhalation Delivery System Reduced Exacerbations, Need for Antibiotics in Patients with Chronic Sinusitis
October 24th 2022
IDWeek 2022: New data show a greater than 60% reduction in acute exacerbations and need for antibiotics in patients with CS who used fluticasone propionate nasal spray.
Real-world Study Suggests Need for Earlier Diagnosis of Non-alcoholic Steatohepatitis
October 21st 2022
Cardiometabolic Health Congress
CMHC 2022: Patients with NASH are often not diagnosed until an advanced stage, and have a high burden of comorbidities, according to new study.
Flash CGM Increases Time in Range for T2D Patients on Noninsulin Therapies Not at Goal HbA1c
June 10th 2022
ADA 2022: Use of flash continuous glucose monitoring in T2D patients not on insulin also reduced HbA1c and glycemic variability, a new study finds.
Continuous Glucose Monitoring Linked to Better Glycemic Control, Reduced Hospitalizations in Study of Veterans Health Administration Data
June 8th 2022
ADA 2022: Large national study found that CGM use had a positive effect on glycemic control and acute complications in T2D in the Veterans Health Administration.